NCT01186159 The Correlation of COX-2 Expression in Human Polymorphonuclear Leukocytes/Macrophages (PMNL/MP) and Postoperative Pain Status COMPLETED Phase PHASE4
NCT01185184 Pharmacokinetics And Safety Study Of Two CP-690,550 Controlled Release Formulation Following Single Dose In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01184092 A Study To Compare The Amount Of Tasocitinib (CP-690,550) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Three Different Tablet Versions Of Tasocitinib (CP-690,550) Status COMPLETED Phase PHASE1
NCT01184001 A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy Subjects Status COMPLETED Phase PHASE1
NCT01181973 Safety, Tolerability and Relative Bioavailability of Pegvisomant in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01181700 A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood After Dosing With Oral Inhalation From Dry Powder Inhalers Status COMPLETED Phase PHASE1
NCT01180049 Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma Status COMPLETED Phase PHASE4
NCT01176916 Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China Status COMPLETED Phase PHASE4
NCT01176058 A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis Status TERMINATED Phase PHASE3
NCT01175135 An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia Status COMPLETED Phase PHASE2
NCT01173757 To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01172821 Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II Status COMPLETED Phase PHASE3
NCT01172808 Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I Status COMPLETED Phase PHASE3
NCT01172652 Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) Status COMPLETED Phase PHASE4
NCT01169714 A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers. Status COMPLETED Phase PHASE1
NCT01168934 A Phase 1 Absolute Bioavailability Study For Oral Crizotinib In Healthy Volunteers Status COMPLETED Phase PHASE1